Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment.

Roden, Dan M; Harrington, Robert A; Poppas, Athena; Russo, Andrea M

Roden, Dan M; Harrington, Robert A; Poppas, Athena; Russo, Andrea M.

J Am Coll Cardiol ; 75(20): 2623-2624, 2020 05 26.

Article in English | MEDLINE | ID: covidwho-276042

Subject(s)

Azithromycin/adverse effects; Betacoronavirus/drug effects; Hydroxychloroquine/adverse effects; Long QT Syndrome/chemically induced; Torsades de Pointes/chemically induced; Anti-Bacterial Agents/adverse effects; Anti-Bacterial Agents/metabolism; Antirheumatic Agents/adverse effects; Antirheumatic Agents/metabolism; Antiviral Agents/adverse effects; Antiviral Agents/metabolism; Azithromycin/metabolism; Betacoronavirus/metabolism; Coronavirus Infections/drug therapy; Coronavirus Infections/metabolism; Drug Interactions/physiology; Drug Repositioning/methods; Electrocardiography/drug effects; Electrocardiography/methods; Humans; Hydroxychloroquine/metabolism; Long QT Syndrome/metabolism; SARS-CoV-2; Torsades de Pointes/metabolism; Torsades de Pointes/physiopathology; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Long QT Syndrome / Torsades de Pointes / Azithromycin / Betacoronavirus / Hydroxychloroquine Limits: Humans Language: English Journal: J Am Coll Cardiol Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google